no photo

Diabetic neuropathy. Treatment. World market.

  • Rating:
  • (0 / 5)
Quick order


The study was conducted in July 2010 as a joint project of RosBusinessConsulting and the Maxwell Biotech Group of Companies. The Maxwell Biotech Venture Fund, which is part of the group of the same name, is Russia's first specialized investment fund in the field of medical innovations and biotechnologies.

This study, jointly prepared by the Maxwell Biotech and RosBusinessConsulting analytical groups, opens the direction for studying the most relevant development segments of the Russian and international pharmaceutical market.

Analytical reference is devoted to the description of the market for drugs for the treatment of diabetic neuropathy (DN). The study examines the main characteristics of the global market, forecasts, methods of diagnosis and treatment, market size, number of patients, market structure, sales of drugs for the treatment of diabetic neuropathy.

Analytical reference includes:

• etiology and pathogenesis of diabetic neuropathy

• description of the global market demand and the potential of the NAM market development

• treatment of diabetic neuropathy and new therapies

The report is supplemented with an English-Russian dictionary of basic terms and abbreviations.

The study was conducted in August 2010.

The volume of the report - 41str.

The report contains 7 tables and 7 graphs and charts.

The report language is Russian.

Categories: Consumer Products / Pharmacies / Medicines

Industry / Pharmaceuticals / Medicines

The whole world

No comments yet
Please rate it

See also:

We are leading agency on market reports sales. More than 10000 market researches in our data base. 


New York, 11th west street, 11

+1 223 324 3234

Follow the news
New York, 11th west street, 11 +1 223 324 3234